FDA grants accelerated approval to Genfit and Ipsen's liver disease drug

FDA grants accelerated approval to Genfit and Ipsen's liver disease drug

Submitted by admin on June 10, 2024 - 6:02pm
Source: 
Reuters
News Tags: 
Genfit
Ipsen
FDA
Ocaliva
primary biliary cholangitis. liver disease
Headline: 
FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
snippet: 

 The U.S. Food and Drug Administration has granted accelerated approval to French drugmakers Ipsen (IPN.PA) and Genfit's (GNFT.PA) to treat a chronic inflammatory liver disease, Ipsen said on Monday.

Do Not Allow Advertisers to Use My Personal information